|
|
|
|
||
of interest"significant efficacy in the neoadjuvant setting with T-DM1,19,20 coupled with excellent tolerability, gives cause for optimism for future incorporation of this drug in early breast cancer, with hopes for an improved therapeutic index" http://jco.ascopubs.org/content/early/2016/07/14/JCO.2016.68.4241.full https://www.melanoma.org/find-support/patient-community/mpip-melanoma-patients-information-page/tdm1-working |
return to message board, top of board |